关键的基因和与帕克利塔克塞尔耐药性相关的分子机制
1Department of Biochemistry, Faculty of Science, University of Tabuk, Tabuk, 71491, Saudi Arabia. aalalawy@ut.edu.sa.
Cancer cell international
|July 13, 2024
概括
癌症中帕克利塔塞尔耐药性是一个主要的挑战,由诸如改变的β-tubulin和药物排泄等机制驱动. 了解这些对标杆菌耐药性途径是开发新的癌症治疗策略的关键.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 帕克利塔塞尔是治疗各种癌症的重要化疗药物.
- 由于帕克利塔克塞尔耐药性的癌症复发限制了治疗的有效性.
- 抵抗的机制包括目标修改和改变药物运输.
研究的目的:
- 审查新兴的分类物耐药性分子机制.
- 识别与耐药性相关的新型遗传和非编码RNA标记物.
- 探索新的治疗策略,以克服对税种的耐药性.
主要方法:
- 关于帕克利塔克塞尔和分类剂耐药性的研究的文献综述.
- 分析分子机制,包括基因和lncRNA表达.
- 在税种之间讨论交叉抵抗模式.
主要成果:
- 帕克利塔克塞尔耐药性涉及β-tubulin和亡调节者的变化.
- 多重耐药基因 (例如,ABCB1,MRP1) 和EDIL3的过度表达有助于耐药性.
- 像H19这样的长非编码RNAs (lncRNAs) 与帕克利塔塞尔耐药性有关.
结论:
- 新兴的分子机制,包括基因和 lncRNA 变化,驱动着对标杆菌的抗性.
- 识别这些机制为新的治疗干预提供了机会.
- 针对抗药性途径可以提高癌细胞对化疗的反应能力.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.4K
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K


